Remove Life Science Remove Pharma R&D Remove Research
article thumbnail

Transforming pharma R&D with a scientist-centric approach to AI & automation

pharmaphorum

Borrowing from the Computer-Aided Design and Manufacturing (CAD/CAM) approaches in the semiconductor industry, a similar concept, called Computer-Aided Biology (CAB), can be applied to the life sciences. Life sciences are on the cusp of a quantum leap, fuelled in part by the spotlight on digitalisation created by the COVID-19 pandemic.

article thumbnail

Why VCs fell in love with pharma R&D in 2021

pharmaphorum

“When you stand back and look at that overall context, what seems to have happened is that pharma and investors have suddenly gone, ‘You know what, maybe you can do these quicker and faster without breaking things’,” says managing director of life sciences and healthcare for Silicon Valley Bank UK, Nooman Haque. “If